DermTech is a San Diego-based biotechnology company developing and commercializing gene expression tests to facilitate the diagnosis of dermatologic conditions. Learn More > DermTech’s Pigmented Lesion Assay provides objective information on gene expression associated with melanoma. Learn more about advanced genetic expression > In studies involving over 500 samples, the Company’s gene classifier has differentiated non-melanoma skin lesions from melanoma with an accuracy of 93%. Learn more about its sensitivity and specificity >